Buprecare 0.3 mg/ml Solution for Injection for Dogs and Cats
Buprecare 0.3 mg/ml Solution for Injection for Dogs and Cats
Authorised
- Buprenorphine hydrochloride
Product identification
Medicine name:
Buprecare 0.3 mg/ml Solution for Injection for Dogs and Cats
BUPRECARE 0,3 MG/ML SOLUTION INJECTABLE POUR CHIENS ET CHATS
Active substance:
- Buprenorphine hydrochloride
Target species:
-
Dog
-
Cat
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Buprenorphine hydrochloride0.32/milligram(s)1.00Ampoule
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Dog
-
Cat
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN02AE01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Package description:
- Presented in 1 ml clear Type I glass, snap ampoule, in boxes of five.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Ecuphar
Marketing authorisation date:
Manufacturing sites for batch release:
- Haupt Pharma Livron
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/3125952 1/2008
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0453/001
Concerned member states:
-
Austria
-
Belgium
-
France
-
Germany
-
Luxembourg
-
Netherlands
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 3/05/2024
French (PDF)
Published on: 4/04/2022
How useful was this page?:
